Akari Therapeutics shareholders approve equity plan increase and director elections

6 days ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Akari Therapeutics shareholders approve equity plan increase and director elections

Related

Golden Goliath Resouces raises $1M privately

Golden Goliath Resouces raises $1M privately

8 minutes ago 0
U.K. fines Monzo £21 million over anti-money laundering lapses

U.K. fines Monzo £21 million over anti-money laundering laps...

10 minutes ago 0
Kevin O’Leary says he remembers the moment he became a millionaire—but it ‘was very anticlimactic’

Kevin O’Leary says he remembers the moment he became a milli...

12 minutes ago 0
Bird flu emergency response ends as cases decline, CDC says

Bird flu emergency response ends as cases decline, CDC says

13 minutes ago 0
‘It’s just bots talking to bots:’ AI is running rampant on college campuses as professors and students lean on the tech

‘It’s just bots talking to bots:’ AI is running rampant on c...

15 minutes ago 0
TopBuild to enter commercial roofing business through Progressive Roofing acquisition

TopBuild to enter commercial roofing business through Progre...

19 minutes ago 0
Ares Strategic Mining secures increased non-dilutive cash injection to support development

Ares Strategic Mining secures increased non-dilutive cash in...

26 minutes ago 0
What to watch in the airline sector as earnings season arrives

What to watch in the airline sector as earnings season arriv...

27 minutes ago 0
Air Lease reports fleet of 495 owned jets, 241 new aircraft on order from Airbus and Boeing

Air Lease reports fleet of 495 owned jets, 241 new aircraft ...

33 minutes ago 0
Investors are buying over 25% of U.S. homes sold, the most in over 5 years, as traditional buyers struggle to afford one

Investors are buying over 25% of U.S. homes sold, the most i...

34 minutes ago 0
Uber is expected to see a modest tailwind from the No Tax on Tips provision

Uber is expected to see a modest tailwind from the No Tax on...

34 minutes ago 0
CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%

CARGO Therapeutics to be acquired by Concentra Biosciences i...

39 minutes ago 0
Laser Photonics GAAP EPS of -$0.12, revenue of $2.3M

Laser Photonics GAAP EPS of -$0.12, revenue of $2.3M

43 minutes ago 0
Trump keeps getting in the way of the rate cut he desperately wants from Jerome Powell 

Trump keeps getting in the way of the rate cut he desperatel...

46 minutes ago 0
Alkaline Water makes strategic expansion into wholesale distribution and manufacturing

Alkaline Water makes strategic expansion into wholesale dist...

52 minutes ago 0
India plans to boost U.S. trade ties with LPG purchase - report

India plans to boost U.S. trade ties with LPG purchase - rep...

1 hour ago 0
Mexico President Sheinbaum calls anti-tourism march over flood of American digital nomads ‘xenophobic’: ‘Gringo: Stop stealing our home’

Mexico President Sheinbaum calls anti-tourism march over flo...

1 hour ago 0
Has Elon Musk really formed a new political party? It’s not clear

Has Elon Musk really formed a new political party? It’s not ...

1 hour ago 0
Nidec buys Chinese scroll compressor maker Xecom

Nidec buys Chinese scroll compressor maker Xecom

1 hour ago 0
Joe Kiani is back: After being ousted from Masimo the billionaire has returned as CEO of Like Minded Labs

Joe Kiani is back: After being ousted from Masimo the billio...

1 hour ago 0

Trending

1. ey
2. tomorrow strike in kerala
3. paypal
4. chennai weather
5. wwe raw results wrestling inc
6. ipl
7. mustafizur rahman
8. mpsc
9. jack dorsey
10. nmmc

Popular

Home Depot is buying GMS for about $4.3 billion as retailer chases more home pros

Home Depot is buying GMS for about $4.3 billion as retailer ...

1 week ago 7
TechCrunch Mobility: The state of EV sales and Rivian secures the next $1B from VW

TechCrunch Mobility: The state of EV sales and Rivian secure...

3 days ago 6
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved